Predicting treatment response using pharmacy register in migraine
Abstract Background Precision medicine may offer new strategies to treat migraine, and access to existing large cohorts may be a key resource to increase statistical power. Treatment response data is not routinely collected for large cohorts; however, such information could be extracted from pharmac...
Main Authors: | Thomas Folkmann Hansen, Mona Ameri Chalmer, Thilde Marie Haspang, Lisette Kogelman, Jes Olesen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-04-01
|
Series: | The Journal of Headache and Pain |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s10194-019-0987-y |
Similar Items
-
Comorbidity of migraine with ADHD in adults
by: Thomas Folkmann Hansen, et al.
Published: (2018-10-01) -
Differences in treatment response between migraine with aura and migraine without aura: lessons from clinical practice and RCTs
by: Jakob Møller Hansen, et al.
Published: (2019-09-01) -
EFFICACY AND TOLERABILITY OF STOPAIN FOR A MIGRAINE ATTACK
by: Andrea eSt. Cyr, et al.
Published: (2015-02-01) -
The Acute Treatment of Migraine Attack in Adults and American Headache Society Evidence Assessment of Migraine Pharmacotherapies
by: Pınar Yalınay Dikmen
Published: (2016-04-01) -
Polygenic risk score: use in migraine research
by: Mona Ameri Chalmer, et al.
Published: (2018-04-01)